ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650958 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650958; 2) Community: the network communities that were significantly associated with the response to NSC 650958; 3) Molecule: the relationships between components within communities and NSC 650958; 4) MDR: the compounds that were significantly associated with the NSC 650958.

NSC Compound Enrichment Correlation
NSC 647328 Null 0.0201565205286441 -0.011824467
NSC 688074 16,24-Cyclo-13,14-secoergost-2-ene-18,26-dioic acid, 5-chloro-14,17:14,27-diepoxy-6,13,20,22-tetrahydroxy-1,15-dioxo-, .gamma.-lactone .delta.-lactone 0.0203119150246193 -0.057968794
NSC 294961 5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one 0.0203119150246197 0.10757367
NSC 670803 1-Octene, 3-(bromomethyl)-2,3,7-trichloro-7-methyl- 0.021946808377072 0.29480856
NSC 678106 Rhamnazin 0.021946808377072 0.21475758
NSC 762901 trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide 0.021946808377072 0.14170653
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0219468083770723 -0.0035565189
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0287230216965525 0.265867
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0287230216965525 0.13784084
NSC 623989 Null 0.0287230216965525 0.11291577
Total:22  Current:8    [First] [Prev] [Next] [Last]